EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Anti‐Doping Testing at FIFA World Cup 2022

Alanod D AlQahtani iD, Wadha Abushareeda, Ariadni Vonaparti, Suhail Kraiem, Wesal ElSaftawy, Khadija Saad, Aisha Al-Wahaibi, Nayla Hilal, Najib Dbes, Vandana Nimker, Alexis Weber, Alka Beotra und 1 weitere

Drug Testing and Analysis · 2025

DOI: 10.1002/dta.3868 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Drug Testing and Analysis, 2025. Verfasst von Alanod D AlQahtani und 12 weiteren Autor:innen. Beteiligte Einrichtung: Anti-Doping Lab-Qatar (ADLQ), Doha, Qatar. Hauptthemen laut MEDLINE: Doping in Sports, Substance Abuse Detection, Performance-Enhancing Substances. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 22nd FIFA World Cup, the world championship for national football teams, was held in Qatar from November 20th to December 18th, 2022. The doping control analysis was successfully conducted by the Anti‐Doping Laboratory Qatar (ADLQ) using its state‐of‐the‐art facilities and instrumentation. To meet the short reporting timeline of 24–72 h, additional staff was recruited, trained, and incorporated into the routine activities during the event period. Furthermore, six scientific experts from other World Anti‐Doping Agency (WADA)‐accredited laboratories were also invited to ensure adequate staffing throughout the event. In total, 57 scientific and non‐scientific staff of ADLQ participated in the FIFA testing. A total of 1612 samples (623 urine, 622 serum, and 367 whole blood samples) were collected and analyzed. The number of serum samples that were tested for hGH using the isoform method had been the highest compared to any other sport event in the past. The results of all the analyzed urine and blood samples were negative, with two cases each being reported to contain the monitoring substance codeine and the confounding factor carboxy finasteride.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Doping in SportsSubstance Abuse DetectionPerformance-Enhancing SubstancesHumansQatarSoccer

Stichwörter der Autor:innen

FIFAQatarWADAWorld Cup 2022anti‐doping lab Qatardoping analysis

Substanzen

Performance-Enhancing Substances

Autor:innen und Institutionen

  • Anti-Doping Lab-Qatar (ADLQ), Doha, Qatar.
  • Institute of Doping Analysis and Sports Biochemistry (IDAS) -, Dresden, Kreischa, Germany.
  • Medicine & Science, Federation Internationale de Football Association, Zürich, Zurich, Switzerland.
  • Centre for Metabolism and Inflammation, Division of Medicine, University College London, London, UK.

ORCID-Profile: Alanod D AlQahtani

Zitieren

APA

AlQahtani, A. D., Abushareeda, W., Vonaparti, A., Kraiem, S., ElSaftawy, W., Saad, K., Al-Wahaibi, A., Hilal, N., Dbes, N., Nimker, V., Weber, A., Beotra, A., & Al Maadheed, M. (2025). Anti‐Doping Testing at FIFA World Cup 2022. Drug Testing and Analysis. https://doi.org/10.1002/dta.3868

Vancouver

AlQahtani AD, Abushareeda W, Vonaparti A, Kraiem S, ElSaftawy W, Saad K, et al. Anti‐Doping Testing at FIFA World Cup 2022. Drug Testing and Analysis. 2025. doi:10.1002/dta.3868

BibTeX
@article{AlQahtani2025,
  author = {AlQahtani, Alanod D and Abushareeda, Wadha and Vonaparti, Ariadni and Kraiem, Suhail and ElSaftawy, Wesal and Saad, Khadija and Al-Wahaibi, Aisha and Hilal, Nayla and Dbes, Najib and Nimker, Vandana and Weber, Alexis and Beotra, Alka and Al Maadheed, Mohammed},
  title = {Anti‐Doping Testing at FIFA World Cup 2022},
  journal = {Drug Testing and Analysis},
  year = {2025},
  doi = {10.1002/dta.3868}
}
Kostenlos starten →